Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-1|1|80|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-2|1|369|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-3|1|405|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-4|1|430|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-5|1|444|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-6|1|457|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-7|1|472|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-8|1|472|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-9|1|476|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-10|1|492|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-11|1|495|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-12|1|502|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-13|1|516|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-14|1|516|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-15|1|520|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-16|1|525|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-17|1|525|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-18|1|534|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-19|1|539|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-20|1|558|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-21|1|574|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-22|1|576|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-23|1|581|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-24|1|597|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-25|1|611|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-26|1|616|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-27|1|618|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-28|1|622|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-29|1|627|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-30|1|627|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-31|1|628|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-32|1|635|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-33|1|640|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-34|1|652|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-35|1|657|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-36|1|658|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-37|1|669|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-38|1|671|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-39|1|672|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-40|1|676|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-41|1|679|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-42|1|685|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-43|1|686|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-44|1|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-45|1|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-46|1|695|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-47|1|697|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-1|n/a,TM KO 1/76|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-1-48|1|704|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-1|2|318|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-2|2|318|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-3|2|318|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-4|2|318|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-5|2|318|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-6|2|319|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-7|2|320|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-8|2|330|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-9|2|344|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-10|2|385|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-11|2|385|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-12|2|385|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-13|2|386|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-14|2|409|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-15|2|421|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-16|2|424|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-17|2|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-18|2|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-19|2|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-20|2|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-21|2|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-22|2|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-23|2|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-24|2|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-25|2|455|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-26|2|483|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-27|2|483|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-28|2|484|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-29|2|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-30|2|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-31|2|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-32|2|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-33|2|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-34|2|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-35|2|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-36|2|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-37|2|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-38|2|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-39|2|516|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-40|2|517|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-41|2|518|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-42|2|527|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-43|2|530|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-44|2|533|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-45|2|533|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-46|2|541|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-47|2|568|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-48|2|568|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-49|2|568|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-50|2|569|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-51|2|575|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-52|2|595|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-53|2|595|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-54|2|595|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-55|2|595|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-56|2|595|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-57|2|595|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-58|2|595|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-59|2|595|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-60|2|596|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-61|2|596|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-62|2|600|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-63|2|604|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-64|2|604|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-65|2|610|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-66|2|610|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-67|2|611|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-68|2|613|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-69|2|621|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-70|2|621|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-71|2|621|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-72|2|621|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-73|2|622|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-74|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-75|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-76|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-77|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-78|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-79|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-80|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-81|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-82|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-83|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-84|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-85|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-86|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-87|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-88|2|688|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-89|2|694|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-90|2|694|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-91|2|695|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-92|2|721|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-93|2|721|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-94|2|721|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-95|2|721|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-2|n/a,TM 5 1/76|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, 102/Ghg|Female|Juvenile|osteosarcoma only|5-6-2-96|2|722|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-1|3|202|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-2|3|424|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-3|3|431|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-4|3|451|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-5|3|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-6|3|525|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-7|3|563|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-8|3|581|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-9|3|530|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-10|3|540|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-11|3|552|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-12|3|561|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-13|3|582|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-14|3|590|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-15|3|699|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-16|3|703|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-17|3|707|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-18|3|707|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-19|3|721|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-20|3|721|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-21|3|729|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-22|3|743|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-23|3|745|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-24|3|748|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-25|3|751|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-26|3|753|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-27|3|762|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-28|3|771|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-29|3|778|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-30|3|780|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-31|3|787|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-32|3|788|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-33|3|802|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-34|3|809|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-35|3|815|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-36|3|826|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-37|3|831|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-38|3|837|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-39|3|839|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-40|3|840|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-41|3|842|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-42|3|863|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-43|3|870|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-44|3|870|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-45|3|872|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-46|3|902|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-47|3|907|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-48|3|925|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-3|n/a,TMC KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-3-49|3|934|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-1|4|308|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-2|4|309|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-3|4|310|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-4|4|325|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-5|4|348|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-6|4|366|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-7|4|366|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-8|4|399|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-9|4|422|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-10|4|432|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-11|4|457|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-12|4|478|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-13|4|483|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-14|4|483|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-15|4|489|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-16|4|494|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-17|4|497|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-18|4|503|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-19|4|504|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-20|4|512|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-21|4|539|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-22|4|544|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-23|4|545|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-24|4|548|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-25|4|551|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-26|4|562|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-27|4|567|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-28|4|589|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-29|4|595|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-30|4|644|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-31|4|653|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-32|4|658|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-33|4|659|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-34|4|661|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-35|4|674|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-36|4|675|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-37|4|679|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-38|4|682|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-39|4|686|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-40|4|715|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-41|4|723|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-42|4|727|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-43|4|741|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-44|4|758|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-45|4|759|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-46|4|794|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-47|4|818|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-48|4|828|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-49|4|831|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-4|n/a,TMC 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|osteosarcoma only|5-6-4-50|4|863|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-1|5|203|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-2|5|239|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-3|5|470|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-4|5|527|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-5|5|535|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-6|5|543|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-7|5|548|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-8|5|567|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-9|5|576|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-10|5|589|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-11|5|602|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-12|5|605|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-13|5|631|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-14|5|647|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-15|5|651|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-16|5|658|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-17|5|662|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-18|5|675|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-19|5|675|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-20|5|690|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-21|5|701|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-22|5|704|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-23|5|711|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-24|5|717|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-25|5|718|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-26|5|724|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-27|5|725|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-28|5|737|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-29|5|741|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-30|5|746|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-31|5|757|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-32|5|757|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-33|5|759|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-34|5|770|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-35|5|770|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-36|5|773|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-37|5|774|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-38|5|778|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-39|5|791|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-40|5|794|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-41|5|794|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-42|5|801|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-43|5|821|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-44|5|948|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-45|5|854|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-46|5|858|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-47|5|858|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-48|5|881|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-49|5|947|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-5|n/a,TMCA KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-5-50|5|980|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-1|6|173|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-2|6|260|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-3|6|281|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-4|6|343|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-5|6|352|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-6|6|372|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-7|6|421|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-8|6|444|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-9|6|448|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-10|6|451|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-11|6|469|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-12|6|494|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-13|6|498|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-14|6|503|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-15|6|537|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-16|6|540|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-17|6|541|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-18|6|552|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-19|6|562|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-20|6|569|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-21|6|577|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-22|6|579|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-23|6|581|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-24|6|583|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-25|6|591|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-26|6|596|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-27|6|612|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-28|6|616|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-29|6|618|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-30|6|622|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-31|6|623|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-32|6|640|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-33|6|652|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-34|6|659|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-35|6|661|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-36|6|667|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-37|6|672|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-38|6|681|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-39|6|682|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-40|6|709|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-41|6|727|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-42|6|729|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-43|6|731|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-44|6|731|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-45|6|737|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-46|6|742|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-47|6|762|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-48|6|828|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-49|6|836|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-6|n/a,TMCA 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, C57BL|Female|Juvenile|osteosarcoma only|5-6-6-50|6|854|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-7|n/a,TMB KO 1/78|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (0 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|n/a|No information on individuals available for this study
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-1|8|167|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-2|8|260|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-3|8|287|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-4|8|322|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-5|8|343|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-6|8|346|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-7|8|349|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-8|8|364|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-9|8|387|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-10|8|402|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-11|8|420|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-12|8|443|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-13|8|451|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-14|8|451|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-15|8|478|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-16|8|531|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-17|8|532|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-18|8|537|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-19|8|539|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-20|8|541|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-21|8|542|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-22|8|548|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-23|8|563|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-24|8|580|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-25|8|597|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-26|8|603|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-27|8|607|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-28|8|618|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-29|8|628|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-30|8|631|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-31|8|651|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-32|8|667|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-33|8|668|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-34|8|672|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-35|8|709|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-36|8|710|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-37|8|713|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-38|8|743|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-39|8|743|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-40|8|745|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-41|8|752|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-42|8|755|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-43|8|766|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-44|8|778|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-45|8|828|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-46|8|828|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-47|8|862|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-48|8|874|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-8|n/a,TMB 5 1/78|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-8-49|8|883|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-1|9|38|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-2|9|38|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-3|9|113|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-4|9|421|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-5|9|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-6|9|532|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-7|9|544|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-8|9|553|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-9|9|574|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-10|9|575|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-11|9|582|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-12|9|588|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-13|9|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-14|9|593|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-15|9|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-16|9|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-17|9|613|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-18|9|614|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-19|9|617|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-20|9|626|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-21|9|628|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-22|9|641|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-23|9|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-24|9|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-25|9|672|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-26|9|677|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-27|9|678|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-28|9|680|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-29|9|691|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-30|9|692|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-31|9|699|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-32|9|701|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-33|9|704|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-34|9|718|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-35|9|724|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-36|9|730|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-37|9|735|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-38|9|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-39|9|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-40|9|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-41|9|788|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-42|9|791|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-43|9|809|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-44|9|837|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-45|9|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-46|9|873|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-47|9|875|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-48|9|876|Other deterministic changes|Whole body|n/a|
5-6-9|n/a,TMG KO 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-9-49|9|893|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-1|10|403|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-2|10|440|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-3|10|461|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-4|10|476|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-5|10|490|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-6|10|491|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-7|10|496|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-8|10|517|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-9|10|528|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-10|10|532|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-11|10|546|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-12|10|551|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-13|10|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-14|10|575|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-15|10|606|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-16|10|616|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-17|10|621|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-18|10|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-19|10|627|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-20|10|643|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|,MPATH: 551 - sarcoma|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-21|10|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-22|10|650|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-23|10|656|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-24|10|661|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-25|10|690|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-26|10|699|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-27|10|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-28|10|701|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-29|10|704|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-30|10|710|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-31|10|713|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-32|10|724|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-33|10|725|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-34|10|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-35|10|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-36|10|734|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-37|10|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-38|10|740|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-39|10|742|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-40|10|749|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-41|10|760|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-42|10|761|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-43|10|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-44|10|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-45|10|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-46|10|796|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-47|10|797|Other deterministic changes|Whole body|n/a|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-48|10|851|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-10|n/a,TMG 0.5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-10-49|10|886|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-1|11|214|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-2|11|228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-3|11|298|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-4|11|312|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-5|11|369|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-6|11|375|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-7|11|378|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-8|11|381|Other deterministic changes|Whole body|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-9|11|407|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-10|11|432|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-11|11|438|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-12|11|441|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-13|11|442|Other deterministic changes|Whole body|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-14|11|446|Other deterministic changes|Whole body|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-15|11|446|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-16|11|456|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-17|11|463|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-18|11|465|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-19|11|477|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-20|11|481|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-21|11|487|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-22|11|488|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-23|11|505|Other deterministic changes|Whole body|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-24|11|530|Other deterministic changes|Whole body|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-25|11|537|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-26|11|543|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-27|11|543|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-28|11|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-29|11|568|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-30|11|578|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-31|11|579|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-32|11|581|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-33|11|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-34|11|593|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-35|11|600|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-36|11|603|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-37|11|609|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-38|11|634|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-39|11|638|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-40|11|641|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-41|11|701|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-42|11|705|Other deterministic changes|Whole body|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-43|11|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-44|11|710|Other deterministic changes|Whole body|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-45|11|712|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-46|11|719|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-47|11|719|Other deterministic changes|Whole body|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-48|11|746|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-49|11|748|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-6-11|n/a,TMG 5 6/79|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, XGF|Female|Juvenile|full pathology|5-6-11-50|11|763|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-1|12|406|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-2|12|496|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-3|12|496|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-4|12|572|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-5|12|670|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-6|12|694|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-7|12|702|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-8|12|717|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-9|12|721|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-10|12|729|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-11|12|738|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-12|12|743|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-13|12|785|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-14|12|785|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-15|12|786|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-16|12|811|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-17|12|818|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-18|12|820|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-19|12|829|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-20|12|848|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-21|12|863|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-22|12|863|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-23|12|869|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-24|12|888|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-25|12|904|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-26|12|905|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-27|12|908|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-28|12|939|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-29|12|939|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-30|12|940|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-31|12|941|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-32|12|951|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-33|12|959|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-34|12|965|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-35|12|978|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-36|12|1010|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-37|12|1028|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-38|12|1032|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-39|12|1056|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-40|12|1066|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-41|12|1069|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-42|12|1071|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-43|12|1072|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-44|12|1080|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-45|12|1098|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-46|12|1104|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-47|12|1130|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-48|12|1146|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-12|n/a,TMS SKOw 2/80|1|28|Th-227 citrate|18.5|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-12-49|12|1157|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-1|13|67|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-2|13|176|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-3|13|209|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-4|13|225|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-5|13|379|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-6|13|410|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-7|13|436|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-8|13|443|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-9|13|443|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-10|13|446|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-11|13|454|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-12|13|474|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-13|13|495|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-14|13|516|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-15|13|561|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-16|13|565|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-17|13|573|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-18|13|573|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-19|13|583|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-20|13|594|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-21|13|599|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-22|13|600|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-23|13|611|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-24|13|653|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-25|13|660|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-26|13|664|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-27|13|679|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-28|13|681|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-29|13|684|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-30|13|692|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-31|13|721|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-32|13|734|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-33|13|740|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-34|13|751|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-35|13|751|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-36|13|763|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-37|13|771|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-38|13|775|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-39|13|775|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-40|13|783|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-41|13|784|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-42|13|789|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-43|13|792|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-44|13|817|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-45|13|817|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-46|13|834|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-47|13|842|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-48|13|849|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-49|13|849|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-50|13|852|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-51|13|863|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-52|13|884|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-53|13|902|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-54|13|919|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-55|13|933|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-56|13|933|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-57|13|984|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-58|13|986|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-59|13|1008|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-13|n/a,TMS SK5w 2/80|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|60 (60 in ERA)|Mouse|Mouse, CBA|Female|Juvenile|osteosarcoma only|5-6-13-60|13|1024|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-1|14|306|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-2|14|574|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-3|14|586|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-4|14|589|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-5|14|644|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-6|14|647|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-7|14|650|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-8|14|651|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-9|14|654|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-10|14|685|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-11|14|694|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-12|14|716|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-13|14|717|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-14|14|728|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-15|14|736|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-16|14|742|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-17|14|752|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-18|14|755|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-19|14|755|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-20|14|755|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-21|14|769|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-22|14|776|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-23|14|778|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-24|14|778|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-25|14|790|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-26|14|820|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-27|14|840|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-28|14|840|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-29|14|856|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-30|14|870|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-31|14|895|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-32|14|896|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-33|14|902|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-34|14|902|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-35|14|906|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-36|14|909|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-37|14|912|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-38|14|931|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-39|14|940|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-40|14|941|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-41|14|944|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-42|14|968|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-43|14|978|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-44|14|978|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-45|14|983|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-46|14|1008|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-47|14|1010|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-48|14|1022|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-49|14|1038|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-14|n/a,TMS SKOm 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-14-50|14|1043|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-1|15|53|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-2|15|281|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-3|15|344|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-4|15|64|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-5|15|368|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-6|15|486|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-7|15|569|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-8|15|609|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-9|15|612|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-10|15|613|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-11|15|639|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-12|15|640|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-13|15|641|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-14|15|661|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-15|15|726|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-16|15|726|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-17|15|745|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-18|15|751|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-19|15|760|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-20|15|777|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-21|15|788|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-22|15|789|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-23|15|823|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-24|15|835|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-25|15|838|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-26|15|850|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-27|15|859|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-28|15|859|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-29|15|864|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-30|15|865|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-31|15|869|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-32|15|870|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-33|15|934|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-34|15|935|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-35|15|949|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-36|15|977|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-37|15|989|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-38|15|1013|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-39|15|1038|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-40|15|1043|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-41|15|1055|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-15|n/a,TMS SK5m 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|42 (42 in ERA)|Mouse|Mouse, CBA|Male|Juvenile|osteosarcoma only|5-6-15-42|15|1055|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-1|16|105|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-2|16|130|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-3|16|159|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-4|16|257|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-5|16|497|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-6|16|499|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-7|16|506|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-8|16|583|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-9|16|585|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-10|16|586|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-11|16|592|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-12|16|592|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-13|16|593|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-14|16|638|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-15|16|644|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-16|16|645|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-17|16|649|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-18|16|652|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-19|16|654|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-20|16|659|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-21|16|667|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-22|16|667|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-23|16|682|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-24|16|682|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-25|16|682|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-26|16|683|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-27|16|698|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-28|16|710|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-29|16|716|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-30|16|757|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-31|16|757|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-32|16|758|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-33|16|759|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-34|16|761|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-35|16|764|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-36|16|782|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-37|16|786|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-38|16|838|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-39|16|855|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-40|16|858|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-41|16|864|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-42|16|864|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-43|16|877|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-44|16|936|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-45|16|942|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-46|16|954|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-47|16|961|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-48|16|967|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-49|16|995|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-16|n/a,TMS BKO 2/80|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-16-50|16|998|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-1|17|84|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-2|17|119|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-3|17|251|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-4|17|278|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-5|17|279|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-6|17|299|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-7|17|320|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-8|17|345|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-9|17|371|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-10|17|372|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-11|17|384|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-12|17|391|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-13|17|415|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-14|17|443|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-15|17|467|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-16|17|467|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-17|17|511|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-18|17|512|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-19|17|513|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-20|17|525|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-21|17|551|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-22|17|554|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-23|17|573|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-24|17|579|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-25|17|602|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-26|17|608|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-27|17|616|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-28|17|617|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-29|17|630|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-30|17|630|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-31|17|642|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-32|17|650|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-33|17|650|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-34|17|651|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-35|17|652|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-36|17|664|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-37|17|666|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-38|17|670|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-39|17|678|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-40|17|678|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-41|17|684|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-42|17|705|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-43|17|716|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-44|17|733|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-45|17|756|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-46|17|775|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-47|17|854|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-48|17|891|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-6-17|n/a,TMS B5 2/80|1|28|Th-227 citrate|185|becquerels per g animal|not applicable or not supplied|single injection|49 (49 in ERA)|Mouse|Mouse, BALB/c|Female|Juvenile|osteosarcoma only|5-6-17-49|17|902|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
